Skip to main navigation Skip to search Skip to main content

Organisation profile

Organisation profile

Introduction

The Wolfson Sensory, Pain and Regeneration Centre (SPaRC) is an academic department embedded within the School of Neuroscience of the Institute of Psychiatry, Psychology and Neuroscience (IoPPN). The department is led by Professors Susan Duty and Elizabeth Bradbury.

Research in the Wolfson Sensory, Pain and Regeneration Centre (SPaRC) focuses on the molecular basis of pain and hearing loss, and on neural repair and regeneration following disease and injury. Our fundamental mission is to understand the biological mechanisms behind these neurological and sensory disorders and harness this knowledge to develop new therapeutic strategies. To achieve these goals, we conduct cutting-edge translational neuroscience research in a positive, inclusive, and collaborative environment.

A core strength of the Wolfson SPaRC is the parallel use of pre-clinical cell and in vivo models, alongside human cellular models, which provides an essential platform for us to forward- and back-translate our fundamental research to and from the clinic. Additional strengths lie in our world-leading expertise in neuroplasticity, interdisciplinary neuro-immune research, high-throughput sequencing technologies, drug discovery and advanced therapeutics.

Our research spans the following areas:

Fingerprint

Dive into the research topics where Wolfson SPaRC is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
  • Advances in migraine prevention

    Martinelli, D., De Icco, R., Al-Khazali, H. M., Ashina, S., Diener, H. C., Dodd-Glover, F., Goicochea, M. T., Jenkins, B., MaassenVanDenBrink, A., Lee, M. J., Özge, A., Peres, M. F. P., Pozo-Rosich, P., Puledda, F., Sacco, S., Schwedt, T., Terwindt, G. M. & Tassorelli, C., Mar 2026, In: The Lancet Neurology. 25, 3, p. 279-293 15 p.

    Research output: Contribution to journalReview articlepeer-review

    3 Citations (Scopus)
  • ADVANTAGE: Advanced discovery of visceral analgesics by neuroimmune targets and the genetics of extreme human phenotype, a study protocol

    Alban-Paccha, M. V., Shenker, N., Teran-Perez, J., Horne, A. W., Malliaras, G., Woods, C. G., ADVANTAGE Consortium, C., Williams, A., Hughes, A., Andersson, D., Denk, F., Horne, A., Saunders, P., Tsanas, A., Malliaras, G., Nik-Zainal, S., Chinnery, P., Shenker, N., Woods, G. & St John Smith, E., 21 May 2026, In: PLoS ONE. 21, 5, e0350169.

    Research output: Contribution to journalArticlepeer-review

    Open Access
    File
  • AhR inhibition promotes axon regeneration via a stress–growth switch

    Halawani, D., Wang, Y., Li, J., Halperin, D., Ni, H., Estill, M., Ramakrishnan, A., Shen, L., Sefiani, A., Geoffroy, C. G., Friedel, R. H. & Zou, H., 1 Apr 2026, (E-pub ahead of print) In: Nature.

    Research output: Contribution to journalArticlepeer-review

    Open Access
    File
    2 Citations (Scopus)
    8 Downloads (Pure)